Mark A Agius

5.0k citations
246 papers · 4.0k · 1 hit paper · h-index 33

Impact in

  • Neurology top 1%
    • Myasthenia Gravis and Thymoma
    • Peripheral Neuropathies and Disorders
    • Autoimmune Neurological Disorders and Treatments
    • Multiple Sclerosis Research Studies

Papers in

    • Schizophrenia research and treatment 46
    • Bipolar Disorder and Treatment 34
    • Myasthenia Gravis and Thymoma 26
    • Peripheral Neuropathies and Disorders 16

Mark A Agius

233 papers receiving 3.7k citations

Mark A Agius's Hit Papers

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial 2014 · 723 citations
7230+4+8Years since publication200400600

Peers

Mark A Agius
Comparison fields: 5 of 148
  • Neurology 999
  • Pathology and Forensic Medicine 1.1k
  • Biological Psychiatry 102
  • Psychiatry and Mental health 525
  • Developmental Neuroscience 72
Replace Scott L. Silliman with:
Scott L. Silliman United States
Adam Ian Kaplin United States
Pádraig Wright United Kingdom
H.J. Adèr Netherlands
Peter Flachenecker Germany
Masoud Etemadifar Iran
Maura Pugliatti Italy
SHARON G. LYNCH United States
Yára Dadalti Fragoso Brazil
Alessandra Solari Italy
Mark A Agius relative to Scott L. Silliman United States Scott L. Silliman's profile →
Citations per field
00.5×1.5×1.8×
Scott L. Silliman · 1×
Citations per year

Countries citing papers authored by Mark A Agius

Since Specialization
Citations

This map shows the geographic impact of Mark A Agius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A Agius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A Agius more than expected).

Fields of papers citing papers by Mark A Agius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A Agius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A Agius. The network helps show where Mark A Agius may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A Agius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A Agius Line = papers co-authored together Mark A Agius links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
2014723
2 2003160
3 1998134
4 2017118
5 202092
6 200086
7
The Psychology of Scars: A Mini-Review.
201863
8
The stress-vulnerability model how does stress impact on mental illness at the level of the brain and what are the consequences?
201062
9 200460
10
The staging model in schizophrenia, and its clinical implications.
201058
11 201655
12 201654
13 200448
14
The use of Music Therapy in the treatment of Mental Illness and the enhancement of Societal Wellbeing.
201847
15
The differences between typical and atypical antipsychotics: the effects on neurogenesis.
201246
16 201445
17 201444
18 200944
19 201544
20 200142

About Mark A Agius

Mark A Agius is a scholar working on Psychiatry and Mental health, Neurology, Clinical Psychology, Biological Psychiatry and Philosophy, having authored 246 papers that have together received 4.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (46 papers), Bipolar Disorder and Treatment (34 papers), Myasthenia Gravis and Thymoma (26 papers), Peripheral Neuropathies and Disorders (16 papers), Multiple Sclerosis Research Studies (16 papers), Mental Health and Psychiatry (16 papers), Mental Health Treatment and Access (13 papers) and Child and Adolescent Psychosocial and Emotional Development (12 papers). The work is most often cited by research in Neurology (999 citations), Pathology and Forensic Medicine (1.1k citations), Biological Psychiatry (102 citations), Psychiatry and Mental health (525 citations) and Developmental Neuroscience (72 citations). Mark A Agius has collaborated with scholars based in United Kingdom, United States and Portugal. Frequent co-authors include David P. Richman, Rashid Zaman, Ricardo A. Maselli, Douglas Jeffery, Kottil W Rammohan, Linda Cappiello, Tracy E. Stites, Philipp von Rosenstiel, Douglas S. Goodin and Peter A. Calabresi. Their work appears in journals such as Annals of the New York Academy of Sciences, European Psychiatry, Neurology, Multiple Sclerosis Journal and Muscle & Nerve.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact